These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 21654615)
21. [Selective Estrogen Receptor Modulators (SERMs) for prevention and treatment of postmenopausal osteoporosis]. Birkhäuser M Ther Umsch; 2012 Mar; 69(3):163-72. PubMed ID: 22403109 [TBL] [Abstract][Full Text] [Related]
22. Assessment of the safety of long-term bazedoxifene treatment on the reproductive tract in postmenopausal women with osteoporosis: results of a 7-year, randomized, placebo-controlled, phase 3 study. Palacios S; de Villiers TJ; Nardone Fde C; Levine AB; Williams R; Hines T; Mirkin S; Chines AA; Maturitas; 2013 Sep; 76(1):81-7. PubMed ID: 23871271 [TBL] [Abstract][Full Text] [Related]
24. The effects of bazedoxifene on mammographic breast density in postmenopausal women with osteoporosis. Harvey JA; Holm MK; Ranganath R; Guse PA; Trott EA; Helzner E Menopause; 2009; 16(6):1193-6. PubMed ID: 19503006 [TBL] [Abstract][Full Text] [Related]
25. Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX. Kanis JA; Johansson H; Oden A; McCloskey EV Bone; 2009 Jun; 44(6):1049-54. PubMed ID: 19254788 [TBL] [Abstract][Full Text] [Related]
26. [SERMs for treatment of osteoporosis: state-of-the-art and perspectives]. Legrand E; Hoppé E; Chappard D; Audran M Gynecol Obstet Fertil; 2006 May; 34(5):423-8. PubMed ID: 16697240 [TBL] [Abstract][Full Text] [Related]
27. Selective estrogen receptor modulators: the future in menopausal treatment. Palacios S Minerva Ginecol; 2011 Jun; 63(3):275-86. PubMed ID: 21654612 [TBL] [Abstract][Full Text] [Related]
38. Incorporating bazedoxifene into the treatment paradigm for postmenopausal osteoporosis in Japan. Ohta H; Solanki J Osteoporos Int; 2015 Mar; 26(3):849-63. PubMed ID: 25448837 [TBL] [Abstract][Full Text] [Related]
39. Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis. Burshell AL; Song J; Dowsett SA; Mershon JL; Delmas PD; Secrest RJ; Cauley JA Curr Med Res Opin; 2008 Mar; 24(3):807-13. PubMed ID: 18254988 [TBL] [Abstract][Full Text] [Related]
40. [Raloxifene (Evista) in the treatment of postmenopausal osteoporosis--the profile of the patient]. Kastelan D; Korsić M Reumatizam; 2005; 52(2):67-70. PubMed ID: 16689133 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]